Lung cancer statistics, 2023
Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population‐based data from the National Cancer Institute, the Centers for Disease C...
Saved in:
| Published in: | Cancer Vol. 130; no. 8; pp. 1330 - 1348 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
Wiley Subscription Services, Inc
15.04.2024
|
| Subjects: | |
| ISSN: | 0008-543X, 1097-0142, 1097-0142 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population‐based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Over the past 5 years, declines in lung cancer mortality became considerably greater than declines in incidence among men (5.0% vs. 2.6% annually) and women (4.3% vs. 1.1% annually), reflecting absolute gains in 2‐year relative survival of 1.4% annually. Improved outcomes likely reflect advances in treatment, increased access to care through the Patient Protection and Affordable Care Act, and earlier stage diagnosis; for example, compared with a 4.6% annual decrease for distant‐stage disease incidence during 2013–2019, the rate for localized‐stage disease rose by 3.6% annually. Localized disease incidence increased more steeply in states with the highest lung cancer screening prevalence (by 3%–5% annually) than in those with the lowest (by 1%–2% annually). Despite progress, disparities remain. For example, Native Americans have the highest incidence and the slowest decline (less than 1% annually among men and stagnant rates among women) of any group. In addition, mortality rates in Mississippi and Kentucky are two to three times higher than in most western states, largely because of elevated historic smoking prevalence that remains. Racial and geographic inequalities highlight longstanding opportunities for more concerted tobacco‐control efforts targeted at high‐risk populations, including improved access to smoking‐cessation treatments and lung cancer screening, as well as state‐of‐the‐art treatment.
Recent declines in lung cancer mortality have outpaced those for incidence, reflecting gains in relative survival that are partly due to recent shifts to earlier stage at diagnosis. Persistent racial and geographic disparities reflect longstanding opportunities for public health intervention to reduce smoking and improve health care access. |
|---|---|
| AbstractList | Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population‐based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Over the past 5 years, declines in lung cancer mortality became considerably greater than declines in incidence among men (5.0% vs. 2.6% annually) and women (4.3% vs. 1.1% annually), reflecting absolute gains in 2‐year relative survival of 1.4% annually. Improved outcomes likely reflect advances in treatment, increased access to care through the Patient Protection and Affordable Care Act, and earlier stage diagnosis; for example, compared with a 4.6% annual decrease for distant‐stage disease incidence during 2013–2019, the rate for localized‐stage disease rose by 3.6% annually. Localized disease incidence increased more steeply in states with the highest lung cancer screening prevalence (by 3%–5% annually) than in those with the lowest (by 1%–2% annually). Despite progress, disparities remain. For example, Native Americans have the highest incidence and the slowest decline (less than 1% annually among men and stagnant rates among women) of any group. In addition, mortality rates in Mississippi and Kentucky are two to three times higher than in most western states, largely because of elevated historic smoking prevalence that remains. Racial and geographic inequalities highlight longstanding opportunities for more concerted tobacco‐control efforts targeted at high‐risk populations, including improved access to smoking‐cessation treatments and lung cancer screening, as well as state‐of‐the‐art treatment.
Recent declines in lung cancer mortality have outpaced those for incidence, reflecting gains in relative survival that are partly due to recent shifts to earlier stage at diagnosis. Persistent racial and geographic disparities reflect longstanding opportunities for public health intervention to reduce smoking and improve health care access. Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population-based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Over the past 5 years, declines in lung cancer mortality became considerably greater than declines in incidence among men (5.0% vs. 2.6% annually) and women (4.3% vs. 1.1% annually), reflecting absolute gains in 2-year relative survival of 1.4% annually. Improved outcomes likely reflect advances in treatment, increased access to care through the Patient Protection and Affordable Care Act, and earlier stage diagnosis; for example, compared with a 4.6% annual decrease for distant-stage disease incidence during 2013-2019, the rate for localized-stage disease rose by 3.6% annually. Localized disease incidence increased more steeply in states with the highest lung cancer screening prevalence (by 3%-5% annually) than in those with the lowest (by 1%-2% annually). Despite progress, disparities remain. For example, Native Americans have the highest incidence and the slowest decline (less than 1% annually among men and stagnant rates among women) of any group. In addition, mortality rates in Mississippi and Kentucky are two to three times higher than in most western states, largely because of elevated historic smoking prevalence that remains. Racial and geographic inequalities highlight longstanding opportunities for more concerted tobacco-control efforts targeted at high-risk populations, including improved access to smoking-cessation treatments and lung cancer screening, as well as state-of-the-art treatment.Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population-based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Over the past 5 years, declines in lung cancer mortality became considerably greater than declines in incidence among men (5.0% vs. 2.6% annually) and women (4.3% vs. 1.1% annually), reflecting absolute gains in 2-year relative survival of 1.4% annually. Improved outcomes likely reflect advances in treatment, increased access to care through the Patient Protection and Affordable Care Act, and earlier stage diagnosis; for example, compared with a 4.6% annual decrease for distant-stage disease incidence during 2013-2019, the rate for localized-stage disease rose by 3.6% annually. Localized disease incidence increased more steeply in states with the highest lung cancer screening prevalence (by 3%-5% annually) than in those with the lowest (by 1%-2% annually). Despite progress, disparities remain. For example, Native Americans have the highest incidence and the slowest decline (less than 1% annually among men and stagnant rates among women) of any group. In addition, mortality rates in Mississippi and Kentucky are two to three times higher than in most western states, largely because of elevated historic smoking prevalence that remains. Racial and geographic inequalities highlight longstanding opportunities for more concerted tobacco-control efforts targeted at high-risk populations, including improved access to smoking-cessation treatments and lung cancer screening, as well as state-of-the-art treatment. Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population-based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Over the past 5 years, declines in lung cancer mortality became considerably greater than declines in incidence among men (5.0% vs. 2.6% annually) and women (4.3% vs. 1.1% annually), reflecting absolute gains in 2-year relative survival of 1.4% annually. Improved outcomes likely reflect advances in treatment, increased access to care through the Patient Protection and Affordable Care Act, and earlier stage diagnosis; for example, compared with a 4.6% annual decrease for distant-stage disease incidence during 2013-2019, the rate for localized-stage disease rose by 3.6% annually. Localized disease incidence increased more steeply in states with the highest lung cancer screening prevalence (by 3%-5% annually) than in those with the lowest (by 1%-2% annually). Despite progress, disparities remain. For example, Native Americans have the highest incidence and the slowest decline (less than 1% annually among men and stagnant rates among women) of any group. In addition, mortality rates in Mississippi and Kentucky are two to three times higher than in most western states, largely because of elevated historic smoking prevalence that remains. Racial and geographic inequalities highlight longstanding opportunities for more concerted tobacco-control efforts targeted at high-risk populations, including improved access to smoking-cessation treatments and lung cancer screening, as well as state-of-the-art treatment. Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer incidence, stage at diagnosis, survival, and mortality using population‐based data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries. Over the past 5 years, declines in lung cancer mortality became considerably greater than declines in incidence among men (5.0% vs. 2.6% annually) and women (4.3% vs. 1.1% annually), reflecting absolute gains in 2‐year relative survival of 1.4% annually. Improved outcomes likely reflect advances in treatment, increased access to care through the Patient Protection and Affordable Care Act, and earlier stage diagnosis; for example, compared with a 4.6% annual decrease for distant‐stage disease incidence during 2013–2019, the rate for localized‐stage disease rose by 3.6% annually. Localized disease incidence increased more steeply in states with the highest lung cancer screening prevalence (by 3%–5% annually) than in those with the lowest (by 1%–2% annually). Despite progress, disparities remain. For example, Native Americans have the highest incidence and the slowest decline (less than 1% annually among men and stagnant rates among women) of any group. In addition, mortality rates in Mississippi and Kentucky are two to three times higher than in most western states, largely because of elevated historic smoking prevalence that remains. Racial and geographic inequalities highlight longstanding opportunities for more concerted tobacco‐control efforts targeted at high‐risk populations, including improved access to smoking‐cessation treatments and lung cancer screening, as well as state‐of‐the‐art treatment. |
| Author | Jemal, Ahmedin Kratzer, Tyler B. Travis, William D. Freedman, Neal D. Bandi, Priti Siegel, Rebecca L. Smith, Robert A. |
| Author_xml | – sequence: 1 givenname: Tyler B. orcidid: 0000-0002-6699-5309 surname: Kratzer fullname: Kratzer, Tyler B. email: tyler.kratzer@cancer.org organization: American Cancer Society – sequence: 2 givenname: Priti surname: Bandi fullname: Bandi, Priti organization: American Cancer Society – sequence: 3 givenname: Neal D. surname: Freedman fullname: Freedman, Neal D. organization: National Cancer Institute – sequence: 4 givenname: Robert A. orcidid: 0000-0003-3344-2238 surname: Smith fullname: Smith, Robert A. organization: American Cancer Society – sequence: 5 givenname: William D. surname: Travis fullname: Travis, William D. organization: Memorial Sloan Kettering Cancer Center – sequence: 6 givenname: Ahmedin orcidid: 0000-0002-0000-4111 surname: Jemal fullname: Jemal, Ahmedin organization: American Cancer Society – sequence: 7 givenname: Rebecca L. surname: Siegel fullname: Siegel, Rebecca L. organization: American Cancer Society |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38279776$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90M1LwzAYBvAgE_ehF88iAy8idr5JmqQ9SvELhoLs4C2kaSodXTqTFtl_b2a3yxBP4YXf85L3GaOBbaxB6BzDDAOQO221m1GGSXKERhhSEQGOyQCNACCJWEw_hmjs_TKMgjB6goY0ISIVgo_Qxbyzn1OtrDZu6lvVVr6ttL-dEiD0FB2XqvbmbPdO0OLxYZE9R_O3p5fsfh5pykQSFZSkmIEuBDPcQJELXJQ4F8ALRRWmOSEs11gzQwwPCQUcSqFSqhgvuaYTdN2vXbvmqzO-lavKa1PXypqm85KkhMUJ4wQCvTqgy6ZzNnwuKJbGGFMsgrrcqS5fmUKuXbVSbiP3ZwcAPdCu8d6ZUupqe3tjW6eqWmKQ22bltln522yI3BxE9lv_xLjH31VtNv9Imb1m733mB7iLhOA |
| CitedBy_id | crossref_primary_10_1007_s12672_025_02983_5 crossref_primary_10_3389_fonc_2025_1652176 crossref_primary_10_62347_MBFJ9966 crossref_primary_10_1093_tbm_ibaf039 crossref_primary_10_3389_fphar_2024_1486783 crossref_primary_10_1016_j_cllc_2024_10_003 crossref_primary_10_1016_j_ijbiomac_2024_135992 crossref_primary_10_1177_15330338251338390 crossref_primary_10_1016_j_molpha_2024_100006 crossref_primary_10_1002_ijc_35188 crossref_primary_10_3390_biomedicines12061239 crossref_primary_10_1007_s00330_025_11461_z crossref_primary_10_1007_s12672_024_01332_2 crossref_primary_10_1093_tbm_ibae074 crossref_primary_10_1002_cncy_70039 crossref_primary_10_1007_s00204_025_04136_7 crossref_primary_10_2147_RMHP_S477529 crossref_primary_10_1038_s41598_025_15095_5 crossref_primary_10_62425_crihs_1703748 crossref_primary_10_61186_ijrr_23_2_9 crossref_primary_10_3390_ph17060776 crossref_primary_10_1088_1758_5090_ad9fe0 crossref_primary_10_1016_j_prenap_2025_100347 crossref_primary_10_3322_caac_70010 crossref_primary_10_1016_j_phrs_2024_107465 crossref_primary_10_3390_genealogy9030097 crossref_primary_10_1016_j_ccr_2025_216779 crossref_primary_10_3390_cancers16244233 crossref_primary_10_3390_jcm13133773 crossref_primary_10_1177_13591053241312672 crossref_primary_10_5114_amsad_209037 crossref_primary_10_1186_s12951_025_03542_4 crossref_primary_10_1200_EDBK_434026 crossref_primary_10_1007_s44178_025_00177_1 crossref_primary_10_1056_EVIDoa2400443 crossref_primary_10_3390_cancers17121950 crossref_primary_10_1093_abm_kaaf020 crossref_primary_10_1016_j_jrras_2024_101174 crossref_primary_10_1002_pon_70048 crossref_primary_10_1007_s00408_024_00756_5 crossref_primary_10_1007_s11701_024_02131_1 crossref_primary_10_1038_s41598_025_01883_6 crossref_primary_10_1016_j_humgen_2024_201312 crossref_primary_10_1007_s12672_025_02269_w crossref_primary_10_1016_j_jtho_2024_06_013 crossref_primary_10_1007_s11427_024_2657_y crossref_primary_10_1016_j_ajhg_2025_07_009 crossref_primary_10_1016_j_canlet_2025_217962 crossref_primary_10_1016_j_asjsur_2025_07_166 crossref_primary_10_1016_j_ibmed_2025_100292 crossref_primary_10_1186_s12890_024_03280_7 crossref_primary_10_1002_cncr_35972 crossref_primary_10_1089_cbr_2025_0078 crossref_primary_10_1055_a_2541_1072 crossref_primary_10_1186_s12885_024_12887_2 crossref_primary_10_7759_cureus_63665 crossref_primary_10_1177_09603271241261307 crossref_primary_10_1186_s12912_025_03153_2 crossref_primary_10_1007_s00228_025_03803_z crossref_primary_10_1016_j_bcp_2024_116345 crossref_primary_10_1016_j_canep_2025_102833 crossref_primary_10_3389_fmed_2024_1497312 crossref_primary_10_1111_cas_70098 crossref_primary_10_1055_a_2657_9494 crossref_primary_10_1053_j_ro_2025_04_007 crossref_primary_10_1016_S0007_4551_25_00152_3 crossref_primary_10_3389_fonc_2025_1638054 crossref_primary_10_1002_cbdv_202402963 crossref_primary_10_3390_cancers17172868 crossref_primary_10_2147_CMAR_S506630 crossref_primary_10_62347_MKBQ5855 crossref_primary_10_1016_j_lungcan_2025_108577 crossref_primary_10_1177_08850666251339451 crossref_primary_10_3389_fonc_2024_1436077 crossref_primary_10_1007_s12668_025_02132_w crossref_primary_10_3390_vaccines13040337 crossref_primary_10_1111_1759_7714_15464 crossref_primary_10_3389_fonc_2024_1452559 crossref_primary_10_3390_biom15060879 crossref_primary_10_1002_slct_202402766 crossref_primary_10_3390_curroncol32090491 crossref_primary_10_3390_ph18091299 crossref_primary_10_1016_j_lungcan_2025_108664 crossref_primary_10_1016_j_lungcan_2025_108661 crossref_primary_10_1007_s00210_024_03238_w crossref_primary_10_1172_JCI191070 crossref_primary_10_1016_j_abst_2024_08_005 crossref_primary_10_1148_ryai_250371 crossref_primary_10_1164_rccm_202406_1168ST crossref_primary_10_1002_cncr_35784 crossref_primary_10_1126_sciadv_adw5001 crossref_primary_10_1134_S1068162024605019 crossref_primary_10_1186_s13019_024_03311_8 crossref_primary_10_1134_S1062359024612436 crossref_primary_10_1016_j_jtho_2025_04_010 crossref_primary_10_1007_s11010_025_05240_z crossref_primary_10_3390_jcm14030770 crossref_primary_10_3390_metabo15050340 crossref_primary_10_1007_s10278_025_01458_x crossref_primary_10_1007_s12257_024_00148_9 crossref_primary_10_1016_j_compbiomed_2025_110638 crossref_primary_10_1002_cncr_35770 crossref_primary_10_1038_s41598_024_63896_x crossref_primary_10_1038_s41598_025_85707_7 crossref_primary_10_1007_s00210_025_03994_3 crossref_primary_10_1053_j_jvca_2025_09_019 crossref_primary_10_3389_fphar_2025_1525210 crossref_primary_10_1096_fj_202501462RR crossref_primary_10_1016_j_athoracsur_2025_07_028 crossref_primary_10_1016_j_jtocrr_2025_100858 crossref_primary_10_3390_biomedicines12071554 crossref_primary_10_1186_s13019_025_03534_3 crossref_primary_10_3390_cancers17111892 crossref_primary_10_1186_s12885_024_13395_z crossref_primary_10_1007_s12668_024_01639_y crossref_primary_10_1038_s41597_025_05742_x crossref_primary_10_1515_oncologie_2024_0232 crossref_primary_10_1080_10408363_2024_2387038 crossref_primary_10_1186_s12957_025_03890_3 crossref_primary_10_1007_s12672_025_03256_x crossref_primary_10_1080_09603123_2025_2534426 crossref_primary_10_1016_j_cpt_2025_09_001 crossref_primary_10_1016_j_jddst_2024_105933 crossref_primary_10_1007_s11033_024_10033_6 crossref_primary_10_17816_onco636670 crossref_primary_10_33590_respiramj_JXDR3449 crossref_primary_10_3390_life15030396 crossref_primary_10_1002_ddr_70036 crossref_primary_10_3390_ijms26083818 crossref_primary_10_1016_j_dyepig_2025_112648 crossref_primary_10_1016_j_jacr_2025_06_014 crossref_primary_10_1016_j_rechem_2025_102358 crossref_primary_10_1038_s41598_025_92590_9 crossref_primary_10_3390_biomedicines12112523 crossref_primary_10_1007_s12672_025_01826_7 crossref_primary_10_3390_cancers17172910 crossref_primary_10_3892_mmr_2025_13618 crossref_primary_10_1016_j_canep_2025_102897 crossref_primary_10_1080_1061186X_2024_2445772 crossref_primary_10_1159_000546745 crossref_primary_10_3389_fsurg_2025_1566902 crossref_primary_10_3390_cancers17152424 crossref_primary_10_1111_1759_7714_70079 crossref_primary_10_1007_s12026_025_09595_9 crossref_primary_10_1016_j_saa_2025_125997 crossref_primary_10_1016_j_prp_2024_155748 crossref_primary_10_1002_advs_202411503 crossref_primary_10_1177_00031348251339526 crossref_primary_10_1002_ddr_70020 crossref_primary_10_1016_j_ejmech_2024_117178 crossref_primary_10_1016_j_bmcl_2025_130096 crossref_primary_10_3390_life15060963 crossref_primary_10_1186_s12885_024_12800_x crossref_primary_10_1186_s13741_025_00538_4 crossref_primary_10_1002_cac2_12627 crossref_primary_10_1007_s10735_024_10339_6 crossref_primary_10_3390_app15074053 crossref_primary_10_1186_s40644_025_00901_0 crossref_primary_10_1002_mco2_70018 crossref_primary_10_3390_toxins17040150 crossref_primary_10_21518_ms2025_096 crossref_primary_10_1097_RLU_0000000000005400 crossref_primary_10_3390_biom14121651 crossref_primary_10_3390_cancers17071231 crossref_primary_10_1016_j_pdpdt_2024_104447 crossref_primary_10_3390_diagnostics15070908 crossref_primary_10_3892_ijo_2024_5690 crossref_primary_10_46879_ukroj_4_2024_504_517 crossref_primary_10_1016_j_canlet_2025_217701 crossref_primary_10_1002_cncr_35833 crossref_primary_10_4103_hemoncstem_HEMONCSTEM_D_25_00025 crossref_primary_10_1080_01635581_2024_2361508 crossref_primary_10_1016_j_clinsp_2025_100662 crossref_primary_10_1177_00333549251341244 crossref_primary_10_1002_fsn3_70608 crossref_primary_10_1016_j_ejca_2025_115303 crossref_primary_10_3389_fmed_2025_1567119 crossref_primary_10_3389_fonc_2025_1564042 crossref_primary_10_3390_md23060241 crossref_primary_10_1111_crj_70026 crossref_primary_10_1016_j_nexres_2025_100490 crossref_primary_10_1038_s41598_025_14587_8 crossref_primary_10_1002_jbt_70024 crossref_primary_10_3389_fonc_2025_1647710 crossref_primary_10_3390_cancers16183116 crossref_primary_10_3390_jcm14020335 crossref_primary_10_3390_ijms25094633 crossref_primary_10_1016_j_prp_2025_155843 crossref_primary_10_3322_caac_21871 crossref_primary_10_1007_s12559_025_10408_2 crossref_primary_10_1016_j_sbsr_2025_100815 crossref_primary_10_3390_cancers16193264 crossref_primary_10_1016_j_genhosppsych_2025_04_004 crossref_primary_10_3390_toxics12120882 crossref_primary_10_3389_fonc_2025_1646851 |
| Cites_doi | 10.7861/clinmedicine.18‐2‐s41 10.3322/caac.21671 10.1371/journal.pone.0017479 10.3322/caac.21763 10.1158/1055‐9965.Epi‐16‐0684 10.1136/tc.9.suppl_2.ii4 10.1001/jamaoncol.2022.2952 10.1038/s41588‐022‐01115‐x 10.1002/cncr.28683 10.1200/JCO.2014.59.5728 10.1016/j.jtcvs.2008.09.026 10.1016/j.amepre.2013.01.019 10.3390/nu7115463 10.21037/jtd.2017.12.61 10.1016/j.ccm.2012.07.001 10.1056/NEJMe2203330 10.1097/00001648‐200011000‐00010 10.1056/nejmoa1911793 10.1177/20406207211048959 10.1002/cncr.34327 10.1056/NEJMsa1211127 10.2307/4591778 10.1001/jamasurg.2022.6826 10.2105/ajph.2013.301844 10.1111/j.1749‐6632.2011.06202.x 10.1093/oxfordjournals.aje.a117467 10.1002/ijc.29915 10.1289/ehp.99107359 10.1093/carcin/bgab082 10.1136/tobaccocontrol‐2020‐056259 10.1259/bjr/98067945 10.1513/AnnalsATS.202003‐262OC 10.1002/onco.13748 10.3390/ijerph15030531 10.1093/ajcn/88.2.372 10.1016/j.chest.2019.12.048 10.1093/jnci/djad069 10.1093/annonc/mds207 10.1080/07370016.2019.1665320 10.1513/pats.200603‐089ms 10.1001/jamanetworkopen.2021.30350 10.3322/caac.21172 10.1158/1055‐9965.Epi‐12‐0023 10.15585/mmwr.mm7218a1 10.1016/j.amepre.2016.05.021 10.1016/S0140‐6736(22)01100‐X 10.1038/s41467‐023‐38196‐z 10.1002/ijc.34272 10.1186/s12890‐020‐1129‐7 10.1001/jama.2021.0377 10.1377/hlthaff.2021.01419 10.1007/s10552‐009‐9300‐8 10.1001/jamanetworkopen.2022.17150 10.1177/1403494815596500 10.1093/jncimonographs/lgu016 10.1136/oem.2009.050120 10.1093/jnci/djac154 10.1016/j.cllc.2015.11.003 10.7326/m22‐1325 10.1177/0962280206070621 10.1093/jnci/djaa211 10.3322/caac.21731 10.1016/j.chest.2023.02.003 10.1164/rccm.201505‐0990OC 10.3322/caac.21654 10.1002/ijc.34217 10.1002/cncr.33996 10.1371/journal.pone.0192999 10.1001/jamaoncol.2020.1040 10.1177/08901171221088849 10.1016/j.jhealeco.2017.06.005 10.15585/mmwr.mm6650a2 10.1136/thorax.55.1.12 10.3322/caac.21811 10.1056/NEJMoa1102873 10.3322/caac.21757 10.1016/j.chest.2021.07.030 10.1136/bmj.38308.477650.63 10.1002/ijc.32486 10.1016/j.jtho.2016.03.025 10.1093/jnci/djr102 10.1016/j.amepre.2013.10.022 10.1001/jamainternmed.2022.6117 10.3390/nu8030134 10.1016/j.amepre.2018.01.001 10.2105/ajph.2014.301933 10.7326/m21‐0252 10.1097/JTO.0000000000000130 10.1056/NEJMoa1208962 10.1016/j.amepre.2014.01.014 10.1111/j.1539‐6924.2011.01703.x 10.1200/JCO.21.02112 10.7326/0003‐4819‐159‐6‐201309170‐00690 10.1093/jnci/djab143 10.1002/cncr.27813 10.1001/jamanetworkopen.2022.15490 10.1016/j.jacr.2013.08.003 10.2105/ajph.94.10.1788 10.1002/ijc.21891 10.1093/ntr/nts014 10.1093/aje/kws151 10.1001/jamaoncol.2019.1402 10.1586/14737140.8.4.605 10.1021/es2025752 10.1289/ehp/1408092 10.2147/lctt.S37319 10.1183/16000617.0045‐2021 10.1093/jnci/djab192 10.1016/S0140‐6736(21)00312‐3 10.1093/annonc/mdy041 10.1093/jnci/djaa170 10.1056/NEJMoa1715907 10.2105/AJPH.2015.302909 10.1016/j.chest.2018.07.029 10.1002/cncr.33573 10.1097/jom.0000000000000258 10.1136/thorax.58.12.1010 10.1183/13993003.00190‐2018 10.1097/JTO.0b013e318206a221 10.1093/jnci/djy206 10.1001/jama.2019.11456 10.1289/ehp.11272 10.1007/s10900‐013‐9681‐1 10.1093/aje/kwg182 10.1080/0284186x.2022.2135134 10.21037/jtd.2020.03.66 10.1037/amp0000331 10.3322/caac.21440 10.1016/j.ejca.2012.01.038 10.1158/1055‐9965.EPI‐16‐0028 10.1016/s0140‐6736(16)32517‐x 10.1093/annonc/mdt119 10.1038/jes.2016.58 10.3322/canjclin.57.4.190 10.1378/chest.123.1_suppl.21s 10.1136/tobaccocontrol‐2011‐050294 10.1158/1055‐9965.epi‐09‐0740 10.1080/09603129973272 10.1056/NEJMoa1916623 10.1001/jama.261.1.49 10.1080/14622200310001649469 10.1080/01635581.2014.894102 10.1001/jamanetworkopen.2023.11966 10.1016/j.chest.2018.10.039 10.1007/s13187‐018‐1420‐y |
| ContentType | Journal Article |
| Copyright | 2024 American Cancer Society. |
| Copyright_xml | – notice: 2024 American Cancer Society. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TO 7U7 C1K H94 K9. NAPCQ 7X8 |
| DOI | 10.1002/cncr.35128 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Oncogenes and Growth Factors Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Oncogenes and Growth Factors Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1097-0142 |
| EndPage | 1348 |
| ExternalDocumentID | 38279776 10_1002_cncr_35128 CNCR35128 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: P30 CA008748 |
| GroupedDBID | --- -~X .3N .GA 05W 0R~ 10A 1CY 1L6 1OC 24P 29B 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 6J9 6P2 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 85S 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AARRQ AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABHFT ABIJN ABIVO ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEIGN AEIMD AENEX AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AIACR AIAGR AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EX3 F00 F01 F04 F5P FD6 FUBAC G-S G.N GNP GODZA GX1 H.X HBH HGLYW HHY HHZ HZ~ IH2 IX1 J0M JPC KBYEO KQQ KZ1 L7B LATKE LAW LC2 LC3 LH4 LITHE LMP LOXES LP6 LP7 LSO LUTES LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 QRW R.K ROL RWI RX1 RYL SJN SUPJJ TEORI UDS UHB V2E V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WVDHM WXI WXSBR XG1 XPP XV2 Z0Y ZGI ZZTAW ~IA ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGXDD AGYGG AIDQK AIDYY CITATION EMOBN O8X CGR CUY CVF ECM EIF NPM 7TO 7U7 C1K H94 K9. NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c3578-d329150cd75e6e0db71df1b706da3a13b225bc1c5e2e6357a060f7a93a56f6c3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 240 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001170349900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0008-543X 1097-0142 |
| IngestDate | Sun Sep 28 02:31:13 EDT 2025 Tue Oct 07 07:19:21 EDT 2025 Sat Jul 26 01:47:20 EDT 2025 Sat Nov 29 07:15:05 EST 2025 Tue Nov 18 22:42:34 EST 2025 Wed Jan 22 16:13:29 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | lung cancer stage at diagnosis cancer statistics cancer surveillance cancer screening survival |
| Language | English |
| License | 2024 American Cancer Society. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3578-d329150cd75e6e0db71df1b706da3a13b225bc1c5e2e6357a060f7a93a56f6c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-3344-2238 0000-0002-0000-4111 0000-0002-6699-5309 |
| PMID | 38279776 |
| PQID | 2959411317 |
| PQPubID | 2045183 |
| PageCount | 19 |
| ParticipantIDs | proquest_miscellaneous_2925485620 proquest_journals_2959411317 pubmed_primary_38279776 crossref_citationtrail_10_1002_cncr_35128 crossref_primary_10_1002_cncr_35128 wiley_primary_10_1002_cncr_35128_CNCR35128 |
| PublicationCentury | 2000 |
| PublicationDate | 15 April 2024 |
| PublicationDateYYYYMMDD | 2024-04-15 |
| PublicationDate_xml | – month: 04 year: 2024 text: 15 April 2024 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Atlanta |
| PublicationTitle | Cancer |
| PublicationTitleAlternate | Cancer |
| PublicationYear | 2024 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2023; 73 2022; 175 2005; 330 2020; 20 2023; 183 2011; 60 2013; 369 2012; 1248 2013; 368 2021; 325 2013; 63 2020; 17 2003; 58 2004; 6 2019; 322 2020; 12 2012; 14 2003; 158 2021; 71 2021; 70 1963; 78 2022; 161 2021; 398 2013; 119 2022; 40 2000; 11 1998; 90 2022; 36 2008; 116 2022; 31 2014; 122 2012; 23 2014; 120 2012; 21 2011; 365 2019; 155 2014; 11 2023; 72 2009; 18 1988 2018; 29 2006; 119 2021; 42 2019; 5 2020; 383 2023; 164 2020; 382 2017; 66 2019; 34 2019; 36 1998 1997 2014; 46 1989; 261 2014; 2014 2020; 146 2016; 17 1999; 107 2011; 6 2012; 33 2012; 32 2022; 114 1999 2016; 11 2018; 18 2015; 192 2023; 152 2022; 5 2022; 8 2023; 158 2012; 48 2020; 158 2012; 46 2018; 10 2017; 389 1995; 141 2016; 8 2018; 15 2018; 13 2021; 26 2022; 72 2013; 24 2023; 6 2022; 73 2021; 369 2021; 127 2000; 9 2015; 33 2008; 8 2016; 106 2021; 30 2014; 66 2010; 67 2020; 6 2012; 176 2021; 113 2000 2013; 159 2000; 55 2018; 378 2015; 43 2014; 9 2022; 128 2003; 123 2019; 111 2014; 56 2022; 400 2022; 151 2023; 14 2015; 5 2021; 4 2009; 20 2013; 44 2017; 26 2019; 74 2010 2017; 27 2006; 15 2009 2016; 51 2022; 41 2006; 3 2015; 7 2007; 57 2009; 137 2010; 83 2018; 68 1999; 9 2022; 386 2011; 103 2018; 154 2004; 94 2012; 3 2021; 12 2013; 38 2023 2022 2021 2022; 61 2020 1964 2023; 115 2018 2016 2018; 51 2016; 138 2021; 174 2008; 88 2015 2014 2022; 54 2009; 2 2018; 54 2014; 104 2018; 57 e_1_2_9_75_1 e_1_2_9_98_1 e_1_2_9_52_1 e_1_2_9_79_1 e_1_2_9_94_1 e_1_2_9_10_1 e_1_2_9_56_1 e_1_2_9_90_1 Centers for Disease Control and Prevention (CDC) (e_1_2_9_23_1) 2023 e_1_2_9_71_1 e_1_2_9_103_1 e_1_2_9_126_1 e_1_2_9_149_1 National Center for Chronic Disease Prevention and Smoking, Office on Smoking and Health (e_1_2_9_68_1) 2014 e_1_2_9_107_1 e_1_2_9_122_1 e_1_2_9_145_1 e_1_2_9_168_1 e_1_2_9_14_1 e_1_2_9_141_1 e_1_2_9_37_1 e_1_2_9_164_1 Burns D (e_1_2_9_11_1) 1997 e_1_2_9_18_1 e_1_2_9_160_1 e_1_2_9_41_1 e_1_2_9_87_1 American Lung Association (e_1_2_9_186_1) 2021 (e_1_2_9_146_1) 2016 Surveillance, Epidemiology, and End Results (SEER) Program (e_1_2_9_26_1) 2022 e_1_2_9_45_1 e_1_2_9_83_1 Dohnegan J (e_1_2_9_189_1) 2022 Garrett BE (e_1_2_9_33_1) 2011; 60 US Department of Health and Human Services (e_1_2_9_135_1) 1998 e_1_2_9_6_1 e_1_2_9_119_1 e_1_2_9_60_1 e_1_2_9_2_1 e_1_2_9_138_1 e_1_2_9_111_1 e_1_2_9_134_1 National Cancer Institute (e_1_2_9_27_1) 2022 e_1_2_9_49_1 e_1_2_9_130_1 e_1_2_9_176_1 e_1_2_9_153_1 e_1_2_9_172_1 e_1_2_9_191_1 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_99_1 Arias E (e_1_2_9_20_1) 2021; 70 e_1_2_9_72_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_95_1 e_1_2_9_76_1 California Medical Association (e_1_2_9_188_1) 2023 e_1_2_9_91_1 National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (e_1_2_9_70_1) 2010 e_1_2_9_102_1 e_1_2_9_148_1 e_1_2_9_129_1 e_1_2_9_144_1 e_1_2_9_167_1 e_1_2_9_106_1 e_1_2_9_125_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_140_1 e_1_2_9_163_1 e_1_2_9_121_1 e_1_2_9_19_1 e_1_2_9_182_1 e_1_2_9_42_1 e_1_2_9_88_1 American Lung Association (e_1_2_9_187_1) 2022 e_1_2_9_61_1 e_1_2_9_46_1 e_1_2_9_84_1 e_1_2_9_80_1 Surgeon General’s Advisory Committee on Smoking and Health (e_1_2_9_136_1) 1964 e_1_2_9_5_1 e_1_2_9_114_1 e_1_2_9_137_1 e_1_2_9_118_1 e_1_2_9_133_1 e_1_2_9_179_1 e_1_2_9_9_1 e_1_2_9_152_1 e_1_2_9_175_1 e_1_2_9_110_1 e_1_2_9_171_1 International Agency for Research on Cancer (IARC) (e_1_2_9_64_1) 1988 e_1_2_9_31_1 e_1_2_9_50_1 e_1_2_9_73_1 Parikh‐Patel A (e_1_2_9_190_1) 2015 National Center for Health Statistics (e_1_2_9_22_1) 2021 e_1_2_9_77_1 e_1_2_9_96_1 e_1_2_9_12_1 e_1_2_9_54_1 Blackburn C (e_1_2_9_185_1) 2018 e_1_2_9_92_1 e_1_2_9_109_1 Moldoveanu B (e_1_2_9_85_1) 2009; 2 US Environmental Protection Agency (EPA) (e_1_2_9_157_1) 2023 e_1_2_9_101_1 e_1_2_9_128_1 e_1_2_9_166_1 e_1_2_9_105_1 e_1_2_9_147_1 National Research Council (US) Committee on Health Risks of Exposure to Radon (BEIR VI) (e_1_2_9_65_1) 1999 e_1_2_9_162_1 e_1_2_9_120_1 e_1_2_9_16_1 e_1_2_9_58_1 e_1_2_9_143_1 Ruhl JL (e_1_2_9_115_1) 2022 Midha A (e_1_2_9_124_1) 2015; 5 Subcommittee on Arsenic in Drinking Water, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission on Life Sciences, Natural Research Council (e_1_2_9_150_1) 1999 e_1_2_9_181_1 University of Kentucky College of Medicine (e_1_2_9_183_1) 2022 e_1_2_9_89_1 e_1_2_9_43_1 e_1_2_9_8_1 e_1_2_9_81_1 e_1_2_9_4_1 e_1_2_9_113_1 e_1_2_9_159_1 US Department of Health and Human Services, Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration (SAMHSA) (e_1_2_9_55_1) 2022 e_1_2_9_117_1 e_1_2_9_155_1 e_1_2_9_178_1 e_1_2_9_151_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_132_1 e_1_2_9_174_1 e_1_2_9_170_1 e_1_2_9_74_1 e_1_2_9_51_1 e_1_2_9_78_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_97_1 e_1_2_9_93_1 e_1_2_9_108_1 e_1_2_9_127_1 e_1_2_9_100_1 e_1_2_9_123_1 e_1_2_9_169_1 e_1_2_9_104_1 US Food and Drug Administration (FDA) (e_1_2_9_62_1) 2022 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_142_1 e_1_2_9_165_1 e_1_2_9_184_1 e_1_2_9_161_1 e_1_2_9_180_1 e_1_2_9_63_1 e_1_2_9_40_1 World Health Organization (WHO) (e_1_2_9_66_1) 2009 e_1_2_9_21_1 e_1_2_9_67_1 e_1_2_9_86_1 Brody DJ (e_1_2_9_69_1) 2021; 369 e_1_2_9_7_1 National Center for Health Statistics (e_1_2_9_44_1) 2021 e_1_2_9_82_1 e_1_2_9_3_1 Fritz A (e_1_2_9_24_1) 2000 Desimone LA (e_1_2_9_156_1) 2014 Office of the Surgeon General (e_1_2_9_39_1) 2020 e_1_2_9_112_1 e_1_2_9_139_1 e_1_2_9_116_1 e_1_2_9_158_1 e_1_2_9_177_1 e_1_2_9_25_1 e_1_2_9_131_1 e_1_2_9_154_1 e_1_2_9_173_1 Benowitz NL (e_1_2_9_35_1) 1998 e_1_2_9_48_1 e_1_2_9_29_1 e_1_2_9_192_1 |
| References_xml | – volume: 114 start-page: 1449 issue: 11 year: 2022 end-page: 1467 article-title: Facilitators and barriers to implementation of lung cancer screening: a framework driven systematic review publication-title: J Natl Cancer Inst – volume: 26 start-page: 376 issue: 3 year: 2017 end-page: 382 article-title: Cancer mortality in Hispanic ethnic groups publication-title: Cancer Epidemiol Biomarkers Prev – volume: 88 start-page: 372 issue: 2 year: 2008 end-page: 383 article-title: Carotenoids and the risk of developing lung cancer: a systematic review publication-title: Am J Clin Nutr – start-page: 13 year: 1997 end-page: 112 – volume: 114 start-page: 78 issue: 1 year: 2022 end-page: 86 article-title: Incidence of lung cancer among never‐smoking Asian American, Native Hawaiian, and Pacific Islander females publication-title: J Natl Cancer Inst – volume: 44 start-page: 472 issue: 5 year: 2013 end-page: 476 article-title: Cigarette price‐minimization strategies by U.S. smokers publication-title: Am J Prev Med – volume: 42 start-page: 1461 issue: 12 year: 2021 end-page: 1474 article-title: Association between previous lung diseases and lung cancer risk: a systematic review and meta‐analysis publication-title: Carcinogenesis – volume: 72 start-page: 475 issue: 18 year: 2023 end-page: 483 article-title: Tobacco product use among adults—United States, 2021 publication-title: MMWR Morb Mortal Wkly Rep – volume: 2 start-page: 1 year: 2009 end-page: 11 article-title: Inflammatory mechanisms in the lung publication-title: J Inflamm Res – volume: 325 start-page: 971 issue: 10 year: 2021 end-page: 987 article-title: Screening for lung cancer with low‐dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force publication-title: JAMA – volume: 3 start-page: 79 year: 2012 end-page: 89 article-title: Lung cancer in women publication-title: Lung Cancer (Auckl) – volume: 138 start-page: 2549 issue: 11 year: 2016 end-page: 2561 article-title: Targeted therapies for treatment of non‐small cell lung cancer—recent advances and future perspectives publication-title: Int J Cancer – volume: 4 issue: 10 year: 2021 article-title: Lung cancer screening eligibility and screening patterns among Black and White adults in the United States publication-title: JAMA Netw Open – volume: 36 start-page: 1208 issue: 7 year: 2022 end-page: 1212 article-title: Barriers and facilitators to lung cancer screening: a physician survey publication-title: Am J Health Promot – year: 2014 – year: 1998 – volume: 40 start-page: 1529 issue: 14 year: 2022 end-page: 1541 article-title: Cancer risks associated with BRCA1 and BRCA2 pathogenic variants publication-title: J Clin Oncol – volume: 51 start-page: 743 issue: 5 year: 2016 end-page: 751 article-title: All Nations Breath of Life: a randomized trial of smoking cessation for American Indians publication-title: Am J Prev Med – volume: 58 start-page: 1010 issue: 12 year: 2003 end-page: 1012 article-title: Air pollution and lung cancer: what more do we need to know? publication-title: Thorax – volume: 192 start-page: 1208 issue: 10 year: 2015 end-page: 1214 article-title: Recent trends in the identification of incidental pulmonary nodules publication-title: Am J Respir Crit Care Med – volume: 71 start-page: 7 issue: 1 year: 2021 end-page: 33 article-title: Cancer statistics, 2021 publication-title: CA Cancer J Clin – volume: 94 start-page: 1788 issue: 10 year: 2004 end-page: 1794 article-title: Barriers to health care access among the elderly and who perceives them publication-title: Am J Public Health – volume: 68 start-page: 31 issue: 1 year: 2018 end-page: 54 article-title: Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States publication-title: CA Cancer J Clin – volume: 63 start-page: 106 issue: 2 year: 2013 end-page: 117 article-title: American Cancer Society lung cancer screening guidelines publication-title: CA Cancer J Clin – volume: 369 start-page: 1 year: 2021 end-page: 8 article-title: Secondhand smoke exposure among nonsmoking adults: United States, 2015–2018 publication-title: NCHS Data Brief – volume: 123 start-page: 21S issue: suppl 1 year: 2003 end-page: 49S article-title: Epidemiology of lung cancer publication-title: Chest – volume: 6 issue: 5 year: 2023 article-title: Prediagnosis smoking cessation and overall survival among patients with non‐small cell lung cancer publication-title: JAMA Netw Open – volume: 27 start-page: 235 issue: 3 year: 2017 end-page: 243 article-title: Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties publication-title: J Expo Sci Environ Epidemiol – volume: 61 start-page: 1256 issue: 10 year: 2022 end-page: 1262 article-title: Increased use of computed tomography in Denmark: stage shift toward early stage lung cancer through incidental findings publication-title: Acta Oncol – volume: 15 start-page: 547 issue: 6 year: 2006 end-page: 569 article-title: Efficient interval estimation for age‐adjusted cancer rates publication-title: Stat Methods Med Res – volume: 154 start-page: 1284 issue: 6 year: 2018 end-page: 1290 article-title: Characteristics and outcomes of small cell lung cancer detected by CT screening publication-title: Chest – year: 2022 – volume: 11 start-page: 673 issue: 6 year: 2000 end-page: 679 article-title: Lung cancer and arsenic concentrations in drinking water in Chile publication-title: Epidemiology – volume: 103 start-page: 810 issue: 10 year: 2011 end-page: 816 article-title: Lung cancer risk among smokers of menthol cigarettes publication-title: J Natl Cancer Inst – volume: 13 issue: 2 year: 2018 article-title: Lung cancer and socioeconomic status in a pooled analysis of case‐control studies publication-title: PLoS One – volume: 119 start-page: 1381 issue: 7 year: 2013 end-page: 1385 article-title: Annual number of lung cancer deaths potentially avertable by screening in the United States publication-title: Cancer – volume: 57 start-page: 290 year: 2018 end-page: 314 article-title: Socioeconomic inequality of access to healthcare: does choice explain the gradient? publication-title: J Health Econ – volume: 74 start-page: 88 issue: 1 year: 2019 end-page: 100 article-title: Understanding the link between racial trauma and substance use among American Indians publication-title: Am Psychol – volume: 54 start-page: 568 issue: 4 year: 2018 end-page: 575 article-title: Challenges implementing lung cancer screening in federally qualified health centers publication-title: Am J Prev Med – volume: 400 start-page: 2 issue: 10345 year: 2022 end-page: 3 article-title: Data aggregation hides Pacific Islander health disparities publication-title: Lancet – volume: 383 start-page: 640 issue: 7 year: 2020 end-page: 649 article-title: The effect of advances in lung‐cancer treatment on population mortality publication-title: N Engl J Med – volume: 46 start-page: 496 issue: 5 year: 2014 end-page: 506 article-title: Smoking among US Hispanic/Latino adults: the Hispanic Community Health Study/Study of Latinos publication-title: Am J Prev Med – volume: 176 start-page: 573 issue: 7 year: 2012 end-page: 585 article-title: Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium publication-title: Am J Epidemiol – volume: 46 start-page: e31 issue: 2 year: 2014 end-page: e37 article-title: Patterns of birth cohort‐specific smoking histories, 1965–2009 publication-title: Am J Prev Med – volume: 2014 start-page: 210 issue: 49 year: 2014 end-page: 217 article-title: The impact of follow‐up type and missed deaths on population‐based cancer survival studies for Hispanics and Asians publication-title: J Natl Cancer Inst Monogr – volume: 26 start-page: 228 issue: 2 year: 2017 end-page: 239 article-title: Determinants of light and intermittent smoking in the United States: results from three pooled national health surveys publication-title: Cancer Epidemiol Biomarkers Prev – volume: 11 start-page: 1204 issue: 8 year: 2016 end-page: 1223 article-title: The IASLC Lung Cancer Staging Project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part‐solid tumors in the forthcoming eighth edition of the TNM Classification of Lung Cancer publication-title: J Thorac Oncol – volume: 72 start-page: 409 issue: 5 year: 2022 end-page: 436 article-title: Cancer treatment and survivorship statistics, 2022 publication-title: CA Cancer J Clin – year: 1964 – volume: 158 start-page: 293 issue: 3 year: 2023 end-page: 301 article-title: Association between surgical quality metric adherence and overall survival among US veterans with early‐stage non–small cell lung cancer publication-title: JAMA Surg – volume: 41 start-page: 281 issue: 2 year: 2022 end-page: 288 article-title: The generational impact of racism on health: voices from American Indian communities publication-title: Health Aff (Millwood) – volume: 18 start-page: s41 issue: suppl 2 year: 2018 end-page: s46 article-title: Recent advances in the management of lung cancer publication-title: Clin Med (Lond) – volume: 23 start-page: 3163 issue: 12 year: 2012 end-page: 3170 article-title: Meat consumption and risk of lung cancer: evidence from observational studies publication-title: Ann Oncol – volume: 90 year: 1998 – volume: 9 start-page: 456 issue: 4 year: 2014 end-page: 463 article-title: Hereditary lung cancer syndrome targets never smokers with germline EGFR gene T790M mutations publication-title: J Thorac Oncol – volume: 66 start-page: 1374 issue: 50 year: 2017 end-page: 1378 article-title: Prevalence and disparities in tobacco product use among American Indians/Alaska Natives—United States, 2010–2015 publication-title: MMWR Morb Mortal Wkly Rep – volume: 14 issue: 1 year: 2023 article-title: Genome‐wide association study of lung adenocarcinoma in East Asia and comparison with a European population publication-title: Nat Commun – volume: 3 start-page: 535 issue: 6 year: 2006 end-page: 537 article-title: State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer publication-title: Proc Am Thorac Soc – volume: 155 start-page: 900 issue: 5 year: 2019 end-page: 907 article-title: The landscape of US lung cancer screening services publication-title: Chest – volume: 6 start-page: S17 issue: uppl 1 year: 2004 end-page: S28 article-title: Menthol pharmacology and its potential impact on cigarette smoking behavior1 publication-title: Nicotine Tob Res – year: 2016 – year: 2010 – volume: 5 start-page: 1318 issue: 9 year: 2019 end-page: 1324 article-title: Evaluation of USPSTF Lung Cancer Screening Guidelines among African American adult smokers publication-title: JAMA Oncol – volume: 33 start-page: 681 issue: 4 year: 2012 end-page: 703 article-title: Occupational and environmental causes of lung cancer publication-title: Clin Chest Med – volume: 111 start-page: 811 issue: 8 year: 2019 end-page: 819 article-title: Racial/ethnic differences in lung cancer incidence in the Multiethnic Cohort Study: an update publication-title: J Natl Cancer Inst – volume: 127 start-page: 2801 issue: 15 year: 2021 end-page: 2806 article-title: Germline mutations and age at onset of lung adenocarcinoma publication-title: Cancer – volume: 43 start-page: 875 issue: 8 year: 2015 end-page: 881 article-title: Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden publication-title: Scand J Public Health – volume: 365 start-page: 395 issue: 5 year: 2011 end-page: 409 article-title: Reduced lung‐cancer mortality with low‐dose computed tomographic screening publication-title: N Engl J Med – volume: 73 start-page: 17 issue: 1 year: 2023 end-page: 48 article-title: Cancer statistics, 2023 publication-title: CA Cancer J Clin – volume: 21 start-page: 728 issue: 5 year: 2012 end-page: 736 article-title: Contribution of screening and survival differences to racial disparities in colorectal cancer rates publication-title: Cancer Epidemiol Biomarkers Prev – volume: 146 start-page: 1503 issue: 6 year: 2020 end-page: 1513 article-title: Lung cancer mortality reduction by LDCT screening—results from the randomized German LUSI trial publication-title: Int J Cancer – volume: 34 start-page: 1142 issue: 6 year: 2019 end-page: 1149 article-title: Challenges to educating smokers about lung cancer screening: a qualitative study of decision making experiences in primary care publication-title: J Cancer Educ – volume: 159 start-page: 411 issue: 6 year: 2013 end-page: 420 article-title: Screening for lung cancer with low‐dose computed tomography: a systematic review to update the US Preventive Services Task Force recommendation publication-title: Ann Intern Med – volume: 128 start-page: 3099 issue: 16 year: 2022 end-page: 3108 article-title: Association of area‐level socioeconomic status and non‐small cell lung cancer stage by race/ethnicity and health care‐level factors: analysis of the National Cancer Database publication-title: Cancer – volume: 73 start-page: 120 issue: 2 year: 2022 end-page: 146 article-title: Cancer statistics for American Indian and Alaska Native individuals, 2022: including increasing disparities in early onset colorectal cancer publication-title: CA Cancer J Clin – volume: 322 start-page: 843 issue: 9 year: 2019 end-page: 856 article-title: Trends in use of medical imaging in US health care systems and in Ontario, Canada, 2000–2016 publication-title: JAMA – volume: 116 start-page: 1675 issue: 12 year: 2008 end-page: 1680 article-title: Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment publication-title: Environ Health Perspect – volume: 83 start-page: 276 issue: 988 year: 2010 end-page: 289 article-title: Incidental findings in imaging diagnostic tests: a systematic review publication-title: Br J Radiol – volume: 5 start-page: 2892 issue: 9 year: 2015 end-page: 2911 article-title: EGFR mutation incidence in non‐small‐cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII) publication-title: Am J Cancer Res – volume: 8 issue: 3 year: 2016 article-title: A healthy dietary pattern reduces lung cancer risk: a systematic review and meta‐analysis publication-title: Nutrients – volume: 54 start-page: 1167 issue: 8 year: 2022 end-page: 1177 article-title: Cross‐ancestry genome‐wide meta‐analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer publication-title: Nat Genet – volume: 261 start-page: 49 issue: 1 year: 1989 end-page: 55 article-title: Trends in cigarette smoking in the United States: the changing influence of gender and race publication-title: JAMA – volume: 174 start-page: 1232 issue: 9 year: 2021 end-page: 1239 article-title: Postdiagnosis smoking cessation and reduced risk for lung cancer progression and mortality: a prospective cohort study publication-title: Ann Intern Med – volume: 26 start-page: 453 issue: 6 year: 2021 end-page: 460 article-title: Disparities in cancer care and the Asian American population publication-title: Oncologist – volume: 6 start-page: 1289 issue: 8 year: 2020 end-page: 1290 article-title: Association of Medicaid expansion under the Patient Protection and Affordable Care Act with non‐small cell lung cancer survival publication-title: JAMA Oncol – volume: 20 start-page: 459 issue: 4 year: 2009 end-page: 471 article-title: Socioeconomic differences in lung cancer incidence: a systematic review and meta‐analysis publication-title: Cancer Causes Control – volume: 183 start-page: 142 issue: 2 year: 2023 end-page: 153 article-title: Healthy eating patterns and risk of total and cause‐specific mortality publication-title: JAMA Intern Med – volume: 8 start-page: 1428 issue: 10 year: 2022 end-page: 1437 article-title: Assessment of lung cancer risk among smokers for whom annual screening is not recommended publication-title: JAMA Oncol – volume: 17 start-page: e5 issue: 2 year: 2016 end-page: e11 article-title: Germline mutation of T790M and dual/multiple EGFR mutations in patients with lung adenocarcinoma publication-title: Clin Lung Cancer – volume: 119 start-page: 741 issue: 4 year: 2006 end-page: 744 article-title: Sex differences in risk of lung cancer: expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts publication-title: Int J Cancer – year: 2009 – volume: 152 start-page: 645 issue: 4 year: 2023 end-page: 660 article-title: Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case‐control studies (SYNERGY) publication-title: Int J Cancer – volume: 386 start-page: 2050 issue: 21 year: 2022 end-page: 2051 article-title: Expanding horizons for treatment of early‐stage lung cancer publication-title: N Engl J Med – volume: 66 start-page: 539 issue: 4 year: 2014 end-page: 549 article-title: Fish consumption and lung cancer risk: systematic review and meta‐analysis publication-title: Nutr Cancer – volume: 21 start-page: 96 issue: 2 year: 2012 end-page: 101 article-title: Stages of the cigarette epidemic on entering its second century publication-title: Tob Control – volume: 113 start-page: 1044 issue: 8 year: 2021 end-page: 1052 article-title: State variation in low‐dose computed tomography scanning for lung cancer screening in the United States publication-title: J Natl Cancer Inst – volume: 20 start-page: 115 issue: 1 year: 2020 article-title: Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program publication-title: BMC Pulm Med – volume: 38 start-page: 976 issue: 5 year: 2013 end-page: 993 article-title: Traveling towards disease: transportation barriers to health care access publication-title: J Community Health – volume: 115 start-page: 822 issue: 7 year: 2023 end-page: 830 article-title: Cancer mortality rates by racial/ethnic groups in the United States, 2018–2020 publication-title: J Natl Cancer Inst – year: 2021 – volume: 30 issue: 162 year: 2021 article-title: Lung cancer is also a hereditary disease publication-title: Eur Respir Rev – volume: 10 start-page: 482 issue: 1 year: 2018 end-page: 497 article-title: Influence of estrogen in non‐small cell lung cancer and its clinical implications publication-title: J Thorac Dis – volume: 15 issue: 3 year: 2018 article-title: Trends and the economic effect of asbestos bans and decline in asbestos consumption and production worldwide publication-title: Int J Environ Res Public Health – volume: 70 start-page: 1 issue: 12 year: 2021 end-page: 27 article-title: Mortality profile of the non‐Hispanic American Indian or Alaska Native population, 2019 publication-title: Natl Vital Stat Rep – volume: 398 start-page: 535 issue: 10299 year: 2021 end-page: 554 article-title: Lung cancer publication-title: Lancet – year: 2018 – volume: 164 start-page: 241 year: 2023 end-page: 251 article-title: Outcomes from more than 1 million people screened for lung cancer with low‐dose CT imaging publication-title: Chest – volume: 104 start-page: 896 issue: 5 year: 2014 end-page: 903 article-title: National trends in smoking behaviors among Mexican, Puerto Rican, and Cuban men and women in the United States publication-title: Am J Public Health – volume: 137 start-page: 807 issue: 4 year: 2009 end-page: 812 article-title: Gender difference in survival of resected non‐small cell lung cancer: histology‐related phenomenon? publication-title: J Thorac Cardiovasc Surg – volume: 60 start-page: 109 issue: 1 year: 2011 end-page: 113 article-title: Cigarette smoking—United States, 1965–2008 publication-title: MMWR Suppl – volume: 7 start-page: 9309 issue: 11 year: 2015 end-page: 9324 article-title: Association of dietary vitamin A and β‐carotene intake with the risk of lung cancer: a meta‐analysis of 19 publications publication-title: Nutrients – volume: 67 start-page: 580 issue: 9 year: 2010 end-page: 584 article-title: Asbestos fibre dimensions and lung cancer mortality among workers exposed to chrysotile publication-title: Occup Environ Med – volume: 151 start-page: 2095 issue: 12 year: 2022 end-page: 2106 article-title: Person‐years of life lost and lost earnings from cigarette smoking‐attributable cancer deaths, United States, 2019 publication-title: Int J Cancer – volume: 141 start-page: 523 issue: 6 year: 1995 end-page: 530 article-title: Case‐control study of bladder cancer and arsenic in drinking water publication-title: Am J Epidemiol – volume: 36 start-page: 165 issue: 4 year: 2019 end-page: 187 article-title: Barriers to healthcare access facing American Indian and Alaska Natives in rural America publication-title: J Community Health Nurs – volume: 6 issue: 3 year: 2011 article-title: Previous lung diseases and lung cancer risk: a systematic review and meta‐analysis publication-title: PLoS One – volume: 71 start-page: 299 issue: 4 year: 2021 end-page: 314 article-title: Racial and socioeconomic disparities in lung cancer screening in the United States: a systematic review publication-title: CA Cancer J Clin – volume: 106 start-page: 246 issue: 2 year: 2016 end-page: 255 article-title: Historical influences on contemporary tobacco use by Northern Plains and Southwestern American Indians publication-title: Am J Public Health – volume: 12 start-page: 2536 issue: 5 year: 2020 end-page: 2544 article-title: Understanding barriers to lung cancer screening in primary care publication-title: J Thorac Dis – volume: 24 start-page: 1918 issue: 7 year: 2013 end-page: 1924 article-title: Cruciferous vegetables consumption and the risk of female lung cancer: a prospective study and a meta‐analysis publication-title: Ann Oncol – volume: 158 start-page: 609 issue: 7 year: 2003 end-page: 616 article-title: Menthol cigarettes and risk of lung cancer publication-title: Am J Epidemiol – volume: 55 start-page: 12 issue: 1 year: 2000 end-page: 18 article-title: Ongoing airway inflammation in patients with COPD who do not currently smoke publication-title: Thorax – volume: 18 start-page: 3349 issue: 12 year: 2009 end-page: 3352 article-title: The convergence of lung cancer rates between Blacks and Whites under the age of 40, United States publication-title: Cancer Epidemiol Biomarkers Prev – volume: 122 start-page: 906 issue: 9 year: 2014 end-page: 911 article-title: Outdoor particulate matter exposure and lung cancer: a systematic review and meta‐analysis publication-title: Environ Health Perspect – volume: 46 start-page: 652 issue: 2 year: 2012 end-page: 660 article-title: Exposure assessment for estimation of the global burden of disease attributable to outdoor air pollution publication-title: Environ Sci Technol – volume: 113 start-page: 1670 issue: 12 year: 2021 end-page: 1682 article-title: Annual Report to the Nation on the Status of Cancer, part 2: patient economic burden associated with cancer care publication-title: J Natl Cancer Inst – volume: 48 start-page: 1957 issue: 13 year: 2012 end-page: 1968 article-title: Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium publication-title: Eur J Cancer – volume: 29 start-page: 959 issue: 4 year: 2018 end-page: 965 article-title: Nivolumab versus docetaxel in previously treated advanced non‐small‐cell lung cancer (CheckMate 017 and CheckMate 057): 3‐year update and outcomes in patients with liver metastases publication-title: Ann Oncol – year: 2015 – volume: 128 start-page: 3099 issue: 16 year: 2022 end-page: 3108 article-title: Association of area‐level socioeconomic status and non–small cell lung cancer stage by race/ethnicity and health care–level factors: analysis of the National Cancer Database publication-title: Cancer – volume: 389 start-page: 255 issue: 10066 year: 2017 end-page: 265 article-title: Atezolizumab versus docetaxel in patients with previously treated non‐small‐cell lung cancer (OAK): a phase 3, open‐label, multicentre randomised controlled trial publication-title: Lancet – volume: 113 start-page: 1590 issue: 11 year: 2021 end-page: 1594 article-title: Using prediction models to reduce persistent racial and ethnic disparities in the draft 2020 USPSTF Lung Cancer Screening Guidelines publication-title: J Natl Cancer Inst – volume: 128 start-page: 1584 issue: 8 year: 2022 end-page: 1594 article-title: Geographic access to lung cancer screening among eligible adults living in rural and urban environments in the United States publication-title: Cancer – volume: 17 start-page: 1264 issue: 10 year: 2020 end-page: 1272 article-title: “We just never have enough time”: clinician views of lung cancer screening processes and implementation publication-title: Ann Am Thorac Soc – volume: 51 issue: 5 year: 2018 article-title: Lung cancer staging: a concise update publication-title: Eur Respir J – volume: 1248 start-page: 107 issue: 1 year: 2012 end-page: 123 article-title: Socioeconomic status and smoking: a review publication-title: Ann N Y Acad Sci – volume: 31 start-page: 556 issue: 4 year: 2022 end-page: 563 article-title: Evaluating the impact of menthol cigarette bans on cessation and smoking behaviours in Canada: longitudinal findings from the Canadian arm of the 2016–2018 ITC Four Country Smoking and Vaping Surveys publication-title: Tob Control – volume: 9 start-page: 131 issue: 2 year: 1999 end-page: 141 article-title: Cancer incidence and high environmental arsenic concentrations in rural populations: results of an ecological study publication-title: Int J Environ Health Res – year: 2000 – volume: 104 start-page: S295 issue: uppl 3 year: 2014 end-page: S302 article-title: Racial misclassification of American Indians and Alaska Natives by Indian Health Service Contract Health Service Delivery Area publication-title: Am J Public Health – volume: 8 start-page: 605 issue: 4 year: 2008 end-page: 615 article-title: Inflammation in the development of lung cancer: epidemiological evidence publication-title: Expert Rev Anticancer Ther – volume: 369 start-page: 920 issue: 10 year: 2013 end-page: 931 article-title: Results of the two incidence screenings in the National Lung Screening Trial publication-title: N Engl J Med – volume: 33 start-page: 2345 issue: 21 year: 2015 end-page: 2352 article-title: Revisiting Li‐Fraumeni syndrome from TP53 mutation carriers publication-title: J Clin Oncol – volume: 161 start-page: 586 issue: 2 year: 2022 end-page: 589 article-title: Lung cancer screening rates during the COVID‐19 pandemic publication-title: Chest – volume: 14 start-page: 1140 issue: 10 year: 2012 end-page: 1144 article-title: Lung cancer mortality risk for U.S. menthol cigarette smokers publication-title: Nicotine Tob Res – volume: 9 start-page: II4 issue: suppl 2 year: 2000 end-page: II8 article-title: Patterns of adolescent smoking initiation rates by ethnicity and sex publication-title: Tob Control – volume: 330 start-page: 223 issue: 7485 year: 2005 article-title: Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case‐control studies publication-title: BMJ – volume: 378 start-page: 1999 issue: 21 year: 2018 end-page: 2009 article-title: Higher lung cancer incidence in young women than young men in the United States publication-title: N Engl J Med – volume: 57 start-page: 190 issue: 4 year: 2007 end-page: 205 article-title: Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities publication-title: CA Cancer J Clin – volume: 107 start-page: 359 issue: 5 year: 1999 end-page: 365 article-title: Drinking water arsenic in Utah: a cohort mortality study publication-title: Environ Health Perspect – volume: 175 start-page: 1501 issue: 11 year: 2022 end-page: 1505 article-title: Characteristics of persons screened for lung cancer in the United States: a cohort study publication-title: Ann Intern Med – volume: 5 issue: 6 year: 2022 article-title: Changes in cancer screening in the US during the COVID‐19 pandemic publication-title: JAMA Netw Open – year: 2023 article-title: Screening for lung cancer: 2023 guideline update from the American Cancer Society publication-title: CA Cancer J Clin – volume: 158 start-page: 386 issue: 1 year: 2020 end-page: 392 article-title: Evaluating knowledge, attitudes, and beliefs about lung cancer screening using crowdsourcing publication-title: Chest – volume: 11 start-page: 378 issue: 4 year: 2014 end-page: 383 article-title: Follow‐up of incidental pulmonary nodules and the radiology report publication-title: J Am Coll Radiol – year: 1988 – volume: 78 start-page: 277 issue: 4 year: 1963 end-page: 283 article-title: Familial aggregation of lung cancer among hospital patients publication-title: Public Health Rep – volume: 5 issue: 6 year: 2022 article-title: US Food and Drug Administration action on menthol cigarettes and flavored cigars—a pivotal moment for health equity publication-title: JAMA Netw Open – year: 2020 – year: 2023 – volume: 120 start-page: 2183 issue: 14 year: 2014 end-page: 2190 article-title: Guideline‐concordant cancer care and survival among American Indian/Alaskan Native patients publication-title: Cancer – volume: 32 start-page: S14 issue: suppl 1 year: 2012 end-page: S24 article-title: Chapter 2: birth‐cohort‐specific estimates of smoking behaviors for the U.S. population publication-title: Risk Anal – volume: 368 start-page: 351 issue: 4 year: 2013 end-page: 364 article-title: 50‐year trends in smoking‐related mortality in the United States publication-title: N Engl J Med – volume: 382 start-page: 503 issue: 6 year: 2020 end-page: 513 article-title: Reduced lung‐cancer mortality with volume CT screening in a randomized trial publication-title: N Engl J Med – volume: 12 year: 2021 article-title: Current and emerging treatment options in primary mediastinal B‐cell lymphoma publication-title: Ther Adv Hematol – volume: 6 start-page: 244 issue: 2 year: 2011 end-page: 285 article-title: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma publication-title: J Thorac Oncol – volume: 56 start-page: 1297 issue: 12 year: 2014 end-page: 1301 article-title: The risk of lung cancer after cessation of asbestos exposure in construction workers using pleural malignant mesothelioma as a marker of exposure publication-title: J Occup Environ Med – year: 1999 – ident: e_1_2_9_120_1 doi: 10.7861/clinmedicine.18‐2‐s41 – volume-title: SEER*Stat software, version 8.4.0 year: 2022 ident: e_1_2_9_26_1 – ident: e_1_2_9_177_1 doi: 10.3322/caac.21671 – ident: e_1_2_9_82_1 doi: 10.1371/journal.pone.0017479 – ident: e_1_2_9_2_1 doi: 10.3322/caac.21763 – ident: e_1_2_9_51_1 doi: 10.1158/1055‐9965.Epi‐16‐0684 – volume-title: Disparities in Stage at Diagnosis, Survival, and Quality of Cancer Care in California by Source of Health Insurance year: 2015 ident: e_1_2_9_190_1 – ident: e_1_2_9_17_1 – ident: e_1_2_9_134_1 doi: 10.1136/tc.9.suppl_2.ii4 – ident: e_1_2_9_165_1 doi: 10.1001/jamaoncol.2022.2952 – ident: e_1_2_9_79_1 doi: 10.1038/s41588‐022‐01115‐x – ident: e_1_2_9_128_1 doi: 10.1002/cncr.28683 – ident: e_1_2_9_74_1 doi: 10.1200/JCO.2014.59.5728 – ident: e_1_2_9_122_1 doi: 10.1016/j.jtcvs.2008.09.026 – volume-title: Arsenic in Drinking Water year: 1999 ident: e_1_2_9_150_1 – volume-title: Smoking Cessation: A Report of the Surgeon General year: 2020 ident: e_1_2_9_39_1 – ident: e_1_2_9_36_1 doi: 10.1016/j.amepre.2013.01.019 – ident: e_1_2_9_91_1 doi: 10.3390/nu7115463 – ident: e_1_2_9_123_1 doi: 10.21037/jtd.2017.12.61 – ident: e_1_2_9_96_1 doi: 10.1016/j.ccm.2012.07.001 – volume: 60 start-page: 109 issue: 1 year: 2011 ident: e_1_2_9_33_1 article-title: Cigarette smoking—United States, 1965–2008 publication-title: MMWR Suppl – ident: e_1_2_9_129_1 doi: 10.1056/NEJMe2203330 – ident: e_1_2_9_149_1 doi: 10.1097/00001648‐200011000‐00010 – volume-title: Joinpoint Regression Program, version 4.9.1.0 year: 2022 ident: e_1_2_9_27_1 – ident: e_1_2_9_161_1 doi: 10.1056/nejmoa1911793 – ident: e_1_2_9_88_1 doi: 10.1177/20406207211048959 – ident: e_1_2_9_140_1 doi: 10.1002/cncr.34327 – ident: e_1_2_9_28_1 doi: 10.1056/NEJMsa1211127 – ident: e_1_2_9_72_1 doi: 10.2307/4591778 – ident: e_1_2_9_131_1 doi: 10.1001/jamasurg.2022.6826 – ident: e_1_2_9_52_1 doi: 10.2105/ajph.2013.301844 – ident: e_1_2_9_138_1 doi: 10.1111/j.1749‐6632.2011.06202.x – volume: 369 start-page: 1 year: 2021 ident: e_1_2_9_69_1 article-title: Secondhand smoke exposure among nonsmoking adults: United States, 2015–2018 publication-title: NCHS Data Brief – ident: e_1_2_9_154_1 doi: 10.1093/oxfordjournals.aje.a117467 – ident: e_1_2_9_117_1 doi: 10.1002/ijc.29915 – ident: e_1_2_9_153_1 doi: 10.1289/ehp.99107359 – ident: e_1_2_9_83_1 doi: 10.1093/carcin/bgab082 – ident: e_1_2_9_60_1 doi: 10.1136/tobaccocontrol‐2020‐056259 – volume-title: Tobacco Use Among U.S. Racial/Ethnic Groups—African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General year: 1998 ident: e_1_2_9_35_1 – volume-title: Tobacco Use Among US Racial/Ethnic Minority Groups—African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General year: 1998 ident: e_1_2_9_135_1 – start-page: 13 volume-title: Changes in Cigarette‐Related Disease Risks and Their Implication for Prevention and Control year: 1997 ident: e_1_2_9_11_1 – ident: e_1_2_9_108_1 doi: 10.1259/bjr/98067945 – volume-title: WHO Handbook on Indoor Radon: A Public Health Perspective year: 2009 ident: e_1_2_9_66_1 – ident: e_1_2_9_170_1 doi: 10.1513/AnnalsATS.202003‐262OC – volume-title: 2018 State of Lung Cancer Report year: 2018 ident: e_1_2_9_185_1 – volume-title: Health Effects of Exposure to Radon (BEIR VI) year: 1999 ident: e_1_2_9_65_1 – ident: e_1_2_9_104_1 doi: 10.1002/onco.13748 – volume-title: Chemical Contaminant Rules year: 2023 ident: e_1_2_9_157_1 – ident: e_1_2_9_101_1 doi: 10.3390/ijerph15030531 – ident: e_1_2_9_151_1 doi: 10.1093/ajcn/88.2.372 – ident: e_1_2_9_173_1 doi: 10.1016/j.chest.2019.12.048 – ident: e_1_2_9_47_1 doi: 10.1093/jnci/djad069 – ident: e_1_2_9_92_1 doi: 10.1093/annonc/mds207 – ident: e_1_2_9_40_1 doi: 10.1080/07370016.2019.1665320 – ident: e_1_2_9_87_1 doi: 10.1513/pats.200603‐089ms – ident: e_1_2_9_168_1 doi: 10.1001/jamanetworkopen.2021.30350 – ident: e_1_2_9_160_1 doi: 10.3322/caac.21172 – ident: e_1_2_9_130_1 doi: 10.1158/1055‐9965.Epi‐12‐0023 – ident: e_1_2_9_139_1 doi: 10.15585/mmwr.mm7218a1 – ident: e_1_2_9_42_1 doi: 10.1016/j.amepre.2016.05.021 – ident: e_1_2_9_182_1 – ident: e_1_2_9_46_1 doi: 10.1016/S0140‐6736(22)01100‐X – ident: e_1_2_9_80_1 doi: 10.1038/s41467‐023‐38196‐z – ident: e_1_2_9_95_1 doi: 10.1002/ijc.34272 – ident: e_1_2_9_110_1 doi: 10.1186/s12890‐020‐1129‐7 – ident: e_1_2_9_21_1 – volume-title: PLACES: Local Data for Better Health year: 2023 ident: e_1_2_9_23_1 – ident: e_1_2_9_163_1 doi: 10.1001/jama.2021.0377 – ident: e_1_2_9_38_1 doi: 10.1377/hlthaff.2021.01419 – volume-title: California: Low screening numbers for lung cancer, high numbers for lack of treatment year: 2022 ident: e_1_2_9_189_1 – ident: e_1_2_9_6_1 doi: 10.1007/s10552‐009‐9300‐8 – ident: e_1_2_9_56_1 doi: 10.1001/jamanetworkopen.2022.17150 – ident: e_1_2_9_99_1 doi: 10.1177/1403494815596500 – ident: e_1_2_9_127_1 doi: 10.1093/jncimonographs/lgu016 – volume-title: National Survey on Drug Use and Health, 2020 year: 2022 ident: e_1_2_9_55_1 – ident: e_1_2_9_98_1 doi: 10.1136/oem.2009.050120 – ident: e_1_2_9_178_1 doi: 10.1093/jnci/djac154 – ident: e_1_2_9_75_1 doi: 10.1016/j.cllc.2015.11.003 – ident: e_1_2_9_103_1 doi: 10.7326/m22‐1325 – volume: 5 start-page: 2892 issue: 9 year: 2015 ident: e_1_2_9_124_1 article-title: EGFR mutation incidence in non‐small‐cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII) publication-title: Am J Cancer Res – volume-title: State of Lung Cancer: 2022 Report year: 2022 ident: e_1_2_9_187_1 – volume-title: Tobacco Product Standard for Menthol in Cigarettes year: 2022 ident: e_1_2_9_62_1 – ident: e_1_2_9_15_1 – ident: e_1_2_9_18_1 – ident: e_1_2_9_25_1 doi: 10.1177/0962280206070621 – ident: e_1_2_9_192_1 doi: 10.1093/jnci/djaa211 – ident: e_1_2_9_29_1 doi: 10.3322/caac.21731 – volume-title: Outdoor Air Pollution year: 2016 ident: e_1_2_9_146_1 – ident: e_1_2_9_166_1 doi: 10.1016/j.chest.2023.02.003 – ident: e_1_2_9_106_1 doi: 10.1164/rccm.201505‐0990OC – ident: e_1_2_9_137_1 doi: 10.3322/caac.21654 – ident: e_1_2_9_3_1 doi: 10.1002/ijc.34217 – ident: e_1_2_9_174_1 doi: 10.1002/cncr.33996 – volume-title: Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service year: 1964 ident: e_1_2_9_136_1 – ident: e_1_2_9_7_1 doi: 10.1371/journal.pone.0192999 – ident: e_1_2_9_105_1 doi: 10.1001/jamaoncol.2020.1040 – volume-title: State of Lung Cancer: 2021 Report year: 2021 ident: e_1_2_9_186_1 – ident: e_1_2_9_171_1 doi: 10.1177/08901171221088849 – ident: e_1_2_9_5_1 doi: 10.1002/cncr.34327 – volume-title: Health, United States: 2019 year: 2021 ident: e_1_2_9_22_1 – ident: e_1_2_9_141_1 doi: 10.1016/j.jhealeco.2017.06.005 – ident: e_1_2_9_34_1 doi: 10.15585/mmwr.mm6650a2 – ident: e_1_2_9_84_1 doi: 10.1136/thorax.55.1.12 – ident: e_1_2_9_102_1 – ident: e_1_2_9_164_1 doi: 10.3322/caac.21811 – ident: e_1_2_9_159_1 doi: 10.1056/NEJMoa1102873 – ident: e_1_2_9_41_1 doi: 10.3322/caac.21757 – ident: e_1_2_9_180_1 doi: 10.1016/j.chest.2021.07.030 – ident: e_1_2_9_67_1 doi: 10.1136/bmj.38308.477650.63 – ident: e_1_2_9_162_1 doi: 10.1002/ijc.32486 – ident: e_1_2_9_114_1 doi: 10.1016/j.jtho.2016.03.025 – ident: e_1_2_9_59_1 doi: 10.1093/jnci/djr102 – ident: e_1_2_9_9_1 doi: 10.1016/j.amepre.2013.10.022 – ident: e_1_2_9_89_1 doi: 10.1001/jamainternmed.2022.6117 – volume-title: Medi‐Cal provider rates to increase under Governor’s budget year: 2023 ident: e_1_2_9_188_1 – ident: e_1_2_9_94_1 doi: 10.3390/nu8030134 – ident: e_1_2_9_184_1 doi: 10.1016/j.amepre.2018.01.001 – ident: e_1_2_9_16_1 doi: 10.2105/ajph.2014.301933 – ident: e_1_2_9_126_1 doi: 10.7326/m21‐0252 – volume: 2 start-page: 1 year: 2009 ident: e_1_2_9_85_1 article-title: Inflammatory mechanisms in the lung publication-title: J Inflamm Res – ident: e_1_2_9_76_1 doi: 10.1097/JTO.0000000000000130 – ident: e_1_2_9_121_1 doi: 10.1056/NEJMoa1208962 – ident: e_1_2_9_53_1 doi: 10.1016/j.amepre.2014.01.014 – ident: e_1_2_9_10_1 doi: 10.1111/j.1539‐6924.2011.01703.x – ident: e_1_2_9_78_1 doi: 10.1200/JCO.21.02112 – volume-title: Health, United States year: 2021 ident: e_1_2_9_44_1 – ident: e_1_2_9_12_1 doi: 10.3322/caac.21763 – ident: e_1_2_9_14_1 doi: 10.7326/0003‐4819‐159‐6‐201309170‐00690 – ident: e_1_2_9_49_1 doi: 10.1093/jnci/djab143 – ident: e_1_2_9_167_1 doi: 10.1002/cncr.27813 – ident: e_1_2_9_179_1 doi: 10.1001/jamanetworkopen.2022.15490 – ident: e_1_2_9_109_1 doi: 10.1016/j.jacr.2013.08.003 – ident: e_1_2_9_142_1 doi: 10.2105/ajph.94.10.1788 – ident: e_1_2_9_31_1 doi: 10.1002/ijc.21891 – ident: e_1_2_9_57_1 doi: 10.1093/ntr/nts014 – volume-title: How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking‐Attributable Disease: A Report of the Surgeon General year: 2010 ident: e_1_2_9_70_1 – ident: e_1_2_9_81_1 doi: 10.1093/aje/kws151 – ident: e_1_2_9_191_1 doi: 10.1001/jamaoncol.2019.1402 – volume-title: IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol. 43. Man‐Made Mineral Fibres and Radon year: 1988 ident: e_1_2_9_64_1 – ident: e_1_2_9_86_1 doi: 10.1586/14737140.8.4.605 – ident: e_1_2_9_145_1 doi: 10.1021/es2025752 – volume-title: Water Quality in Principal Aquifers of the United States, 1991–2010 year: 2014 ident: e_1_2_9_156_1 – ident: e_1_2_9_144_1 doi: 10.1289/ehp/1408092 – ident: e_1_2_9_32_1 doi: 10.2147/lctt.S37319 – ident: e_1_2_9_71_1 doi: 10.1183/16000617.0045‐2021 – ident: e_1_2_9_4_1 doi: 10.1093/jnci/djab192 – volume-title: The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General year: 2014 ident: e_1_2_9_68_1 – ident: e_1_2_9_116_1 doi: 10.1016/S0140‐6736(21)00312‐3 – ident: e_1_2_9_119_1 doi: 10.1093/annonc/mdy041 – ident: e_1_2_9_181_1 doi: 10.1093/jnci/djaa170 – volume-title: Gov. Beshear Signs Bill Establishing Lung Cancer Screening Program year: 2022 ident: e_1_2_9_183_1 – ident: e_1_2_9_30_1 doi: 10.1056/NEJMoa1715907 – ident: e_1_2_9_43_1 doi: 10.2105/AJPH.2015.302909 – ident: e_1_2_9_158_1 doi: 10.1016/j.chest.2018.07.029 – ident: e_1_2_9_19_1 – ident: e_1_2_9_77_1 doi: 10.1002/cncr.33573 – ident: e_1_2_9_97_1 doi: 10.1097/jom.0000000000000258 – ident: e_1_2_9_148_1 doi: 10.1136/thorax.58.12.1010 – ident: e_1_2_9_112_1 doi: 10.1183/13993003.00190‐2018 – ident: e_1_2_9_113_1 doi: 10.1097/JTO.0b013e318206a221 – ident: e_1_2_9_48_1 doi: 10.1093/jnci/djy206 – ident: e_1_2_9_107_1 doi: 10.1001/jama.2019.11456 – ident: e_1_2_9_100_1 doi: 10.1289/ehp.11272 – volume-title: Summary Stage 2018: Codes and Coding Instructions year: 2022 ident: e_1_2_9_115_1 – ident: e_1_2_9_143_1 doi: 10.1007/s10900‐013‐9681‐1 – ident: e_1_2_9_58_1 doi: 10.1093/aje/kwg182 – ident: e_1_2_9_111_1 doi: 10.1080/0284186x.2022.2135134 – ident: e_1_2_9_169_1 doi: 10.21037/jtd.2020.03.66 – ident: e_1_2_9_176_1 doi: 10.7326/m22‐1325 – ident: e_1_2_9_37_1 doi: 10.1037/amp0000331 – ident: e_1_2_9_8_1 doi: 10.3322/caac.21440 – ident: e_1_2_9_73_1 doi: 10.1016/j.ejca.2012.01.038 – ident: e_1_2_9_54_1 doi: 10.1158/1055‐9965.EPI‐16‐0028 – ident: e_1_2_9_118_1 doi: 10.1016/s0140‐6736(16)32517‐x – ident: e_1_2_9_90_1 doi: 10.1093/annonc/mdt119 – volume-title: International Classification of Diseases for Oncology year: 2000 ident: e_1_2_9_24_1 – ident: e_1_2_9_155_1 doi: 10.1038/jes.2016.58 – ident: e_1_2_9_50_1 doi: 10.3322/canjclin.57.4.190 – ident: e_1_2_9_147_1 doi: 10.1378/chest.123.1_suppl.21s – ident: e_1_2_9_63_1 doi: 10.1136/tobaccocontrol‐2011‐050294 – ident: e_1_2_9_132_1 doi: 10.1158/1055‐9965.epi‐09‐0740 – ident: e_1_2_9_152_1 doi: 10.1080/09603129973272 – ident: e_1_2_9_13_1 doi: 10.1056/NEJMoa1916623 – ident: e_1_2_9_133_1 doi: 10.1001/jama.261.1.49 – volume: 70 start-page: 1 issue: 12 year: 2021 ident: e_1_2_9_20_1 article-title: Mortality profile of the non‐Hispanic American Indian or Alaska Native population, 2019 publication-title: Natl Vital Stat Rep – ident: e_1_2_9_61_1 doi: 10.1080/14622200310001649469 – ident: e_1_2_9_93_1 doi: 10.1080/01635581.2014.894102 – ident: e_1_2_9_125_1 doi: 10.1001/jamanetworkopen.2023.11966 – ident: e_1_2_9_175_1 doi: 10.1016/j.chest.2018.10.039 – ident: e_1_2_9_172_1 doi: 10.1007/s13187‐018‐1420‐y – ident: e_1_2_9_45_1 |
| SSID | ssj0007253 |
| Score | 2.7312777 |
| SecondaryResourceType | review_article |
| Snippet | Despite decades of declining mortality rates, lung cancer remains the leading cause of cancer death in the United States. This article examines lung cancer... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1330 |
| SubjectTerms | Cancer screening cancer statistics cancer surveillance Diagnosis Disease control Early Detection of Cancer Female Humans Incidence Lung cancer Lung Neoplasms - epidemiology Lung Neoplasms - therapy Male Medical screening Mortality Native Americans Neoplasms - therapy Patient Protection & Affordable Care Act 2010-US Patient Protection and Affordable Care Act Registries SEER Program Smoking stage at diagnosis Survival Tobacco United States - epidemiology |
| Title | Lung cancer statistics, 2023 |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.35128 https://www.ncbi.nlm.nih.gov/pubmed/38279776 https://www.proquest.com/docview/2959411317 https://www.proquest.com/docview/2925485620 |
| Volume | 130 |
| WOSCitedRecordID | wos001170349900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1097-0142 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007253 issn: 0008-543X databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1097-0142 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0007253 issn: 0008-543X databaseCode: WIN dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50V8SL70d1lYpeFOs2SdO04EVWFwUtIivuraRJepKu1Mfvd9J2K6II4q2lU9JkXl-S5huAw5xrKnIWeDj50V4gBcZBicGQKD_SBPFpoPyq2IRIkmg8ju9m4Gx6Fqbmh2gX3KxnVPHaOrjMXvqfpKGqUOUpw3wVzUKXouHyDnQv7ocPN20kFrRhofQjjwds3NKT0v7n218T0jeU-RW0VllnuPS_712GxQZtuue1eazAjClWYf622U9fg94N-rqrrOZL154tqmmbT1xb7nwdRsPL0eDKa-oleMpy1nia0RjxndKCm9D4OhNE5yQTfqglk4Rl6LuZIoobaiwNnfRDPxcyZpKHeajYBnSKSWG2wI0NN9oorgJt8VQgQ65Cy0Vvgpxqyh04mo5ZqhoucVvS4imtWZBpanubVr114KCVfa4ZNH6U6k2HPm286CWlMY8DQhDiOLDfPkb7t5sasjCTNyuDU9wIUZzvwGatsrYZFlGB-DZ04LjSzC_tp4NkcF9dbf9FeAcWUCHVrzyE96DzWr6ZXZhT76ivcg9mxTjaa6wS7x6vkw_HXuD- |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7oFPXF-6U6taIvinXNrWkfZTg23IrIwL2VNEmfpJPp_P0mbdcxFEF8K_SUNDm3L7fvAFxlTGGeEeqZyY_yqOAmDgoTDJH0Q4UMPqXSL4pN8DgOR6PoqTqbY-_ClPwQ9YKb9YwiXlsHtwvSrTlrqMzl5I6YhBUuwwo1SMNWbnjpxXUg5rgiofRDj1EyqtlJcWv-7WI--gYyFzFrkXQ6W__83W3YrNCme1-axw4s6XwX1gbVfvoeNPvG111pNT9x7d2ikrb51rXlzvdh2HkYtrteVS_Bk5azxlMERwbfScWZDrSvUo5UhlLuB0oQgUhqfDeVSDKNtaWhE37gZ1xERLAgCyQ5gEY-zvURuJFmWmnJJFUWT1ERMBlYLnpNM6wwc-B6NmiJrLjEbUmL16RkQcaJ7W1S9NaBy1r2rWTQ-FGqORv7pPKi9wRHLKIIGYjjwEX92ti_3dQQuR5PrYyZ4oYGxfkOHJY6q5shIeYG3wYO3BSq-aX9pB23n4un478In8N6dzjoJ_1e_HgCG0Y5xbEexJrQ-JhM9Smsyk-ju8lZYZpfEUbhyQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7oJuKL90t1akVfFOuaW9M-yuZQnGOMCXsrWZI-STeq8_ebtF3HUATxrdBT0uTkO_ly-w7AVcIU5gmhnpn8KI8KbuKgMMEQST9UyPBTKv082QTv9cLRKOqXZ3PsXZhCH6JacLPIyOO1BbieqqS5UA2VqczuiBmwwlWoU5tFpgb19qDz2q1CMcelDKUfeoySUaVPipuLr5dHpG80c5m15sNOZ-ufP7wNmyXfdO-LDrIDKzrdhfWXckd9Dxpdg3ZXWt9nrr1dVAg337o24fk-DDsPw9ajV2ZM8KRVrfEUwZFheFJxpgPtqzFHKkFj7gdKEIHI2KB3LJFkGmsrRCf8wE-4iIhgQRJIcgC1dJLqI3AjzbTSkkmqLKOiImAysGr0miZYYebA9bzRYlmqidukFm9xoYOMY1vbOK-tA5eV7bTQ0PjRqjFv-7jE0XuMIxZRhAzJceCiem0QYLc1RKonM2tjJrmh4XG-A4eFz6piSIi5YbiBAze5a34pP271WoP86fgvxuew3m934u5T7_kENoxv8nM9iDWg9pHN9CmsyU_juuys7Jtfapficg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lung+cancer+statistics%2C+2023&rft.jtitle=Cancer&rft.au=Kratzer%2C+Tyler+B&rft.au=Bandi%2C+Priti&rft.au=Freedman%2C+Neal+D&rft.au=Smith%2C+Robert+A&rft.date=2024-04-15&rft.issn=1097-0142&rft.eissn=1097-0142&rft.volume=130&rft.issue=8&rft.spage=1330&rft_id=info:doi/10.1002%2Fcncr.35128&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon |